Stockscreener 앱 받기
10.58
0.19%
0.02
Nurix Therapeutics Inc 주식(NRIX)의 최신 뉴스
Technical Bounce Expected in Nurix Therapeutics Inc. Next Week2025 Institutional Moves & Comprehensive Market Scan Reports - metal.it
Is Nurix Therapeutics Inc. trending in predictive chart modelsWeekly Stock Analysis & Weekly Top Gainers Trade List - Newser
Using fundamentals and technicals on Nurix Therapeutics Inc.Market Volume Summary & Community Consensus Stock Picks - Newser
How sentiment analysis helps forecast Nurix Therapeutics Inc.Breakout Watch & Daily Stock Trend Watchlist - Newser
Is Nurix Therapeutics Inc. stock poised for growth2025 EndofYear Setup & Daily Risk Controlled Trade Plans - Newser
What technical models suggest about Nurix Therapeutics Inc.’s comebackRecession Risk & Safe Entry Point Identification - Newser
Nurix Therapeutics (NASDAQ:NRIX) Shares Up 7.7%What's Next? - MarketBeat
How Nurix Therapeutics Inc. stock performs during market volatilityPortfolio Performance Summary & Low Risk Entry Point Guides - Newser
Sector ETF performance correlation with Nurix Therapeutics Inc.Weekly Trade Recap & High Return Trade Opportunity Guides - Newser
Does Nurix Therapeutics Inc. stock pay reliable dividendsPortfolio Gains Report & Accurate Buy Signal Notifications - Newser
Trend analysis for Nurix Therapeutics Inc. this weekJuly 2025 Highlights & Reliable Entry Point Trade Alerts - Newser
Real time scanner hits for Nurix Therapeutics Inc. explainedEntry Point & Low Risk Entry Point Tips - Newser
Can Nurix Therapeutics Inc. Escape Recent Bear ChannelInvestment Strategy Designed for Capital Protection - beatles.ru
Risks Still Elevated At These Prices As Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Dive 25% - 富途牛牛
Dimensional US Core Equity 2 ETF (DFAC) Implied Analyst Target Price: $41.37, With 12.92% Upside Expected. - AInvest
Victory Capital Management Inc. Has $352,000 Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Houte Hans Van Sells 5,402 Shares - MarketBeat
Equity Inducement as a Growth Engine: How Nurix Therapeutics Aligns Talent and Shareholder Value in Biotech Innovation - AInvest
What makes Nurix Therapeutics Inc. stock price move sharplyGet exclusive market analysis for investors - Jammu Links News
Is Nurix Therapeutics Inc. stock overvalued or undervaluedUnstoppable investment returns - Jammu Links News
Nurix Therapeutics Inc. Stock Analysis and ForecastConsistent triple returns - Jammu Links News
Why is Nurix Therapeutics Inc. stock attracting strong analyst attentionHigh-yield portfolio picks - Jammu Links News
How many analysts rate Nurix Therapeutics Inc. as a “Buy”Access high-yield investment alerts now - Jammu Links News
What are analysts’ price targets for Nurix Therapeutics Inc. in the next 12 monthsDiscover breakthrough stocks with expert help - Jammu Links News
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Insider Sells $51,739.08 in Stock - MarketBeat
What is Nurix Therapeutics Inc. company’s growth strategyCapitalize on emerging investment opportunities - Jammu Links News
What are Nurix Therapeutics Inc. company’s key revenue driversUnlock powerful trading signals for profits - Jammu Links News
Is it the right time to buy Nurix Therapeutics Inc. stockDiscover high-impact investment opportunities - Jammu Links News
Analysts Set Nurix Therapeutics, Inc. (NASDAQ:NRIX) PT at $29.31 - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Up 4.9%Time to Buy? - MarketBeat
When is Nurix Therapeutics Inc. stock expected to show significant growthAdvanced Screener Data Feed To Watch Now - Jammu Links News
Nurix Therapeutics CFO Hans van Houte sells 5402 shares at $11.03 per share. - AInvest
Oppenheimer Reiterates "Outperform" Rating for Nurix Therapeutics (NASDAQ:NRIX) - MarketBeat
Y Intercept Hong Kong Ltd Buys Shares of 31,458 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Sells $51,691.04 in Stock - MarketBeat
Oppenheimer Reiterates Outperform Rating for Nurix Therapeutics (NRIX) | NRIX Stock News - GuruFocus
Oppenheimer Adjusts Price Target for Nurix Therapeutics (NRIX) - GuruFocus
Will Nurix Therapeutics Inc. benefit from macro trendsGrowth Focused Entry Plan Suggestions Issued - metal.it
ARK Investment Management LLC Has $18.90 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Real time social sentiment graph for Nurix Therapeutics Inc.Profit Focused Stock Screener Results Released - metal.it
Nurix therapeutics (NRIX) CSO Hansen sells $51k in stock By Investing.com - Investing.com Australia
Nurix Therapeutics CFO van Houte sells $51,695 in shares By Investing.com - Investing.com South Africa
Nurix Therapeutics’ ring sells $46k in stock to cover tax obligations - Investing.com India
Nurix therapeutics (NRIX) CSO Hansen sells $51k in stock - Investing.com
Nurix Therapeutics CFO van Houte sells $51,695 in shares - Investing.com
Will Nurix Therapeutics Inc. Hold Gains Into CloseMulti-Bagger Potential Stock Forecast Tools Released - metal.it
0.41%
0.88%
자본화:
|
볼륨(24시간):